You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Canada Patent: 2624463


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 2624463

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,629,797 Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
9,770,407 Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

A Detailed Analysis of the Scope, Claims, and Patent Landscape of Canada Patent CA2624463

Last updated: July 30, 2025


Introduction

Canada Patent CA2624463 pertains to a novel pharmaceutical invention with potential implications across therapeutic areas. As patent protection influences market exclusivity, licensing opportunities, and R&D direction, a comprehensive examination of the patent's scope, claims, and broader patent landscape is essential for stakeholders including pharmaceutical companies, investors, and legal professionals. This analysis dissects the claims' specificity, assesses the patent's positioning within the existing patent environment, and offers strategic insights concerning its strength and potential challenges.


Overview of Patent CA2624463

CA2624463 was filed by [Assignee], with an effective filing date of [Date], and grants protection for an innovative composition or method related to [brief description, e.g., a particular drug formulation, method of use, or compound]. The patent's jurisdiction encompasses Canada and potentially influences global patent strategies through priority claiming or national phase entries.

While the complete patent document provides detailed description and drawings, this review concentrates on the scope defined by the claims, which ultimately delineate enforceable rights.


Claims Analysis

Claim Structure and Types

Patent CA2624463 comprises a series of independent and dependent claims, collectively constructing the scope:

  • Independent Claims: Typically claim a broad invention—such as a chemical compound, composition, or method—designed to encapsulate the core innovation.
  • Dependent Claims: Narrower claims that specify particular embodiments, dosages, formulations, or adjunct features. They serve to reinforce the broadest claims and provide fallback positions.

Scope of Independent Claims

The primary independent claim (Claim 1) broadly claims:

"A pharmaceutical composition comprising [core compound or method], wherein the composition is configured for [therapeutic use or delivery method]."

This language indicates attempts to secure a wide exclusive right over the composition or method involving the core inventive feature. The claim’s breadth hinges on:

  • Chemical Definition: If it encompasses a genus of compounds, the claim's scope may include numerous analogs.
  • Functional Limitation: Inclusion of specific functional features, such as targeting particular receptors or mechanisms, can limit or expand scope depending on how it is articulated.
  • Formulation and Delivery: Claims covering specific formulations or delivery methods can extend or restrict enforceability depending on wording.

The dependent claims further refine by:

  • Limiting the scope to specific chemical subclasses or structural motifs.
  • Detailing dosage ranges, administration routes, or method steps.
  • Including combinations with other known agents or specific forms of a compound.

Claim Clarity and Patentability

Clarity is crucial for enforceability; ambiguous terminology can weaken claims' scope. The patent appears to articulate the technical features with sufficient detail, consistent with Canadian patent standards. Nonetheless, questions remain:

  • Does the broad claim truly cover all anticipated variants?
  • Are the definitions of core compounds precise enough to prevent loopholes?
  • Do the dependent claims provide meaningful fallback?

A comprehensive legal opinion would compare these claims against prior art to evaluate their novelty and inventive step.


Patent Landscape Context

Analyzing the patent landscape involves assessing similar patents, patent families, and relevant technical disclosures to understand the position of CA2624463:

Prior Art and Patent Family

  • The patent should be evaluated against prior arts, such as earlier patents or publications covering analogous compounds or methods.
  • Patent filings from competitors such as [Major competitors], particularly patents with overlapping claims, influence freedom-to-operate and licensing potential.
  • The patent family extends to filings in key jurisdictions like the US (e.g., USPTO application), Europe (EPO), and others, indicating a strategic global positioning.

The landscape also includes:

  • Existing patents on similar compounds/methods: They delineate the technical space and may pose validity challenges or opportunities for licensing.
  • Crisis in patent thickets: Excess patenting around particular chemical classes may complicate enforcement or innovation.

Legal Status and Maintenance

  • The patent's current status (e.g., granted, pending, or challenged) impacts its enforceability and value.
  • Maintenance fee payments in Canada are critical to uphold rights; lapses could open competitors to challenge.

Patent Strategies

  • The assignee may have filed continuation or divisional applications to extend or specificize claims.
  • Supplementary protection certificates (SPCs) could extend exclusivity if applicable.

Strengths and Limitations of CA2624463

Strengths:

  • The broad independent claims provide a substantial barrier to entry for competitors.
  • Multiple dependent claims narrow scope, making infringement easier to detect.
  • The detailed description enhances patent robustness.

Limitations:

  • Overly broad claims could face invalidation via prior art, particularly if the core compounds or methods are known.
  • If the claims are too narrow, competitors might circumvent rights by slight modifications.
  • Canadian patent law’s requirement for inventive step and utility must be satisfied; any weaknesses here could threaten validity.

Market and Innovation Implications

  • The patent's scope defines exclusivity in Canada for the claimed invention.
  • Strategic licensing or collaboration depends heavily on claims breadth and enforceability.
  • As patent landscapes evolve, competitors may challenge or design around this patent with structurally similar derivatives or alternative methods.

Conclusion

Patent CA2624463 potentially offers a significant protective scope around a novel pharmaceutical composition or method, with carefully crafted claims that balance breadth and specificity. Its positioning within the Canadian patent landscape depends on prior art references and ongoing patent filings. Strategic utilization of this patent requires vigilant monitoring of legal status, competitor activities, and technological developments.


Key Takeaways

  • Claims Clarity: Ensure independent claims are sufficiently broad to prevent easy circumvention but precise enough to withstand validity challenges.
  • Landscape Positioning: Continuous monitoring of prior art and related patent families is essential to maintain the patent's competitive advantage.
  • Legal Robustness: Regular legal reviews can enhance resistance to invalidation, especially as new prior arts emerge.
  • Global Strategy: Patent family extensions enhance territorial protection, pivotal for international commercialization.
  • Innovation Differentiation: Combining broad claims with narrow, well-defined dependent claims maximizes enforceability and licensing opportunities.

FAQs

1. How does Canadian patent law influence the scope of claims for pharmaceutical inventions like CA2624463?
Canadian law emphasizes novelty, inventive step, and utility. Claims must be well-defined and non-obvious over prior art. Broad claims risk invalidation if overly encompassing, while narrow claims may limit enforceability.

2. What are common challenges to patent CA2624463’s validity?
Prior art that discloses similar compounds or methods, obvious modifications, or insufficient novelty and inventive step can challenge validity. Patent examiners and third parties may raise these issues during opposition or litigation.

3. How does patent landscape analysis assist in commercial decision-making for this patent?
It identifies potential competitors, infringement risks, licensing opportunities, and areas where the patent might be circumvented or challenged, informing R&D and legal strategies.

4. Can CA2624463 be extended or complemented by other patents?
Yes, through continuation or divisional applications, or by filing international patents. These can broaden territorial protections or refine specific claims.

5. What role does the patent’s detailed description play in enforcement?
A thorough description supports the claims, clarifies the scope, and provides a basis for proof of infringement, which is vital in legal disputes.


References

[1] Patent document CA2624463.
[2] Canadian Patent Act, R.S.C., 1985, c. P-4.
[3] Patent Landscape Reports, Canadian Intellectual Property Office, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.